These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33405428)

  • 1. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.
    Wang J; Li X
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
    Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
    J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis.
    Li X; Liu L; Hu Y
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32162652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.
    Chang Y; Liu Q; Zhou Z; Ding Y; Yang M; Xu W; Chen K; Zhang Q; Wang Z; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820934881. PubMed ID: 32552476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients: A Systematic Review and Meta-analysis.
    Wong YJ; Qiu TY; Ng GK; Zheng Q; Teo EK
    J Clin Gastroenterol; 2021 Aug; 55(7):615-623. PubMed ID: 33606427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
    Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
    BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
    Kim G; Jang SY; Nam CM; Kang ES
    J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Pinyopornpanish K; Al-Yaman W; Butler RS; Carey W; McCullough A; Romero-Marrero C
    Am J Gastroenterol; 2021 Nov; 116(11):2258-2269. PubMed ID: 34212895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
    Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
    Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis.
    Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT
    Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma.
    Singh J; Wozniak A; Cotler SJ; Dhanarajan A; Aldrich D; Park D; Kasia C; Schmidt B; Scaglione S
    J Clin Gastroenterol; 2022 Apr; 56(4):369-373. PubMed ID: 33883511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.
    Thrift AP; Natarajan Y; Liu Y; El-Serag HB
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2117-2125.e3. PubMed ID: 30625400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Fatty Liver Disease.
    Zou B; Odden MC; Nguyen MH
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):435-444.e6. PubMed ID: 35158055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between statin use and the risk, prognosis of gynecologic cancer: A meta-analysis.
    Chen Y; Han L; Zheng A
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():74-81. PubMed ID: 34875557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
    Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
    Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.
    Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H
    Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
    Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
    PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality.
    Vell MS; Loomba R; Krishnan A; Wangensteen KJ; Trebicka J; Creasy KT; Trautwein C; Scorletti E; Seeling KS; Hehl L; Rendel MD; Zandvakili I; Li T; Chen J; Vujkovic M; Alqahtani S; Rader DJ; Schneider KM; Schneider CV
    JAMA Netw Open; 2023 Jun; 6(6):e2320222. PubMed ID: 37358849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.